Dr Ross Tomlinson is a strong advocate for clinical trials and local research, ensuring regional patients have access to the latest treatment options close to home. He is committed to providing individualised, patient-centred care, and works collaboratively with his patients, their loved ones and general practitioners to achieve the best possible outcomes.

Biography

Dr Ross Tomlinson is a clinical haematologist at Icon Cancer Centre Wesley and Icon Cancer Centre Chermside. He is experienced in caring for a wide range of malignant and non-malignant blood disorders including lymphoma, leukaemia, multiple myeloma, myelodysplastic syndromes, thrombosis and haemostasis.

In 2012 he completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Bond University and subsequently undertook specialist clinical and laboratory haematology training at the Royal Brisbane and Women’s Hospital and Toowoomba Base Hospital. Dr Tomlinson maintains a strong interest in clinical trials, research and medical education. He has published several clinical research articles in leading peer-reviewed journals and is a regular presenter at national and international haematology conferences. Dr Tomlinson is also an associate lecturer at the University of Queensland.

He is a fellow of the Royal Australasian College of Physicians (FRACP) and Royal College of Pathologists of Australasia (FRCPA). Dr Tomlinson is also a member of several leading cancer trial and research groups including the Australasian Leukaemia & Lymphoma Group (ALLG), American Society of Haematology (ASH) and Haematology Society of Australia and New Zealand (HSANZ).

Affiliations & Memberships

Australian Medical Association (AMA)
American Society of Haematology (ASH)
Australasian Leukaemia and Lymphoma Group (ALLG)
Haematology Society of Australia and New Zealand (HSANZ)
Royal Australasian College of Physicians (RACP)
Royal College of Pathologists of Australasia (RCPA)

Special Interests

Dr Ross Tomlinson accepts referrals for malignant and non-malignant blood disorders, with a special clinical interest in:

Haematology
Leukaemia
Lymphoma
Multiple myeloma
Myelodysplasia
Thrombosis and haemostasis

Icon Locations

Wesley View centre

Chermside View centre

Visiting Locations

St Andrew’s Ipswich Private Hospital

Publications

Bortezomib use and outcomes for the treatment of multiple myeloma. C. Loke, P. Mollee, I. McPherson, E. Walpole, M. Yue, H. Mutsando, P. Wong, H. Weston, R. Tomlinson & S. Hollingworth. Journal of Internal Medicine, 2020; 50(9): 1059-1066.
Validation of the Boston University staging system in AL amyloidosis. R. Tomlinson, N. Matigian & P. Mollee. Amyloid, 2019; 26(3): 125-127.
Thrombotic thrombocytopenic purpura associated with Hodgkin lymphoma and non-Hodgkin lymphoma. Tomlinson & J. Yaxley. Pathology, 2018; 50(7): 776-777.
Multiple myeloma: updated approach to management 2018. R. Tomlinson. Australian Journal of General Practice, 2018; 47(8): 526-529.
Chronic lymphocytic leukaemia: an updated approach to diagnosis and management in general practice. Australian Family Physician, 2017; 46(7): 493-496.